Bioenergy Capital AG logo

BIY - Bioenergy Capital AG Share Price

€0.27 0.0  0.0%

Last Trade - 31/03/17

Sector
Financials
Size
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 1046
Bullish
Bearish
Unlock BIY Revenue
Momentum
Relative Strength (%)
1m +1.50%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 01st Jan 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: :
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BIY Revenue Unlock BIY Revenue

Net Income

BIY Net Income Unlock BIY Revenue

Normalised EPS

BIY Normalised EPS Unlock BIY Revenue

PE Ratio Range

BIY PE Ratio Range Unlock BIY Revenue

Dividend Yield Range

BIY Dividend Yield Range Unlock BIY Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BIY EPS Forecasts Unlock BIY Revenue
Profile Summary

Bioenergy Capital AG is a Germany-based investment company that invests in companies from the areas of health care, medicine, nutrition and cosmetics. The Company holds interest in Vitis Traubenkern GmbH and Bioenergy Healthcare GmbH. Vitis Traubenkern GmbH offers natural grape seed products, such as grape seed oil, flavored oils, grape seed flour, grape seed capsules and grape seed granulate for private customers as dietary supplements and for the cosmetic and pet care industries. Bioenergy Healthcare GmbH produces and markets nutritional medicine products for the dietary treatment of hepatic dysfunction, an elevated homocysteine level, age-related macular degeneration (AMD) and homocysteine-associated circulatory disorders.

Directors
Last Annual January 1st, 1970
Last Interim January 1st, 1970
Public Since December 27, 2012
No. of Shareholders: n/a
No. of Employees: n/a
Sector Financials
Industry Investment Banking & Investment Services
Index
Exchange Munich Stock Exchange
Shares in Issue
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BIY Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BIY
Upcoming Events for BIY
Frequently Asked Questions for Bioenergy Capital AG
What is the Bioenergy Capital AG share price?

As of 31/03/17, shares in Bioenergy Capital AG are trading at €0.27, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Bioenergy Capital AG share price performed this year?

Shares in Bioenergy Capital AG are currently trading at €0.27 and the price has moved by -81.38% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioenergy Capital AG price has moved by -82.2% over the past year.

What are the analyst and broker recommendations for Bioenergy Capital AG?

There are no analysts currently covering Bioenergy Capital AG.

When will Bioenergy Capital AG next release its financial results?

It is not known when Bioenergy Capital AG will next release financial results.

What is the Bioenergy Capital AG dividend yield?

Bioenergy Capital AG does not currently pay a dividend.

Does Bioenergy Capital AG pay a dividend?

Bioenergy Capital AG does not currently pay a dividend.

When does Bioenergy Capital AG next pay dividends?

Bioenergy Capital AG does not currently pay a dividend.

How do I buy Bioenergy Capital AG shares?

To buy shares in Bioenergy Capital AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Bioenergy Capital AG?

Shares in Bioenergy Capital AG are currently trading at €0.27, giving the company a market capitalisation of £n/a.

Where are Bioenergy Capital AG shares listed? Where are Bioenergy Capital AG shares listed?

Here are the trading details for Bioenergy Capital AG:

Country of listing: Germany
Exchange: MUN
Ticker Symbol: BIY
What kind of share is Bioenergy Capital AG?

We were not able to load our ranking data for Bioenergy Capital AG

Is there a Bioenergy Capital AG share price forecast 2021?

We were not able to load any forecast data for Bioenergy Capital AG.

How can I tell whether the Bioenergy Capital AG share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioenergy Capital AG. Over the past six months, the relative strength of its shares against the market has been -74.36%. At the current price of €0.27, shares in Bioenergy Capital AG are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Bioenergy Capital AG PE Ratio?

We were not able to find PE ratio data for Bioenergy Capital AG.

Who are the key directors of Bioenergy Capital AG?

We were unable to find the directors for Bioenergy Capital AG.

Who are the major shareholders of Bioenergy Capital AG?

Here are the top five shareholders of Bioenergy Capital AG based on the size of their shareholding:

Similar to BIY
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.